Navigation Links
Oncothyreon reports full year and fourth quarter 2008 financial results
Date:3/9/2009

......... 23,388 212 24,416 528 Licensing, royalties and other revenue............ - 80 - 103 --------- --------- --------- --------- 36,024 1,938 39,998 3,798 --------- --------- --------- --------- Expenses Research and development.............. 2,401 2,278 9,318 10,011 Manufacturing............. 10,527 1,396 13,675 2,564 General and administrative........... 2,444 3,567 9,749 11,797 Marketing and business development.............. - 26 - 565 Amortization.............. 105 84 422 246 Investment and other (income) expense......... (177) (19) (291) 376 Change in fair value of warrant liability........ - (242) - (1,421) --------- --------- --------- --------- 15,300 7,090 32,873 24,138 --------- --------- --------- --------- Net income (loss)........... 20,724 (5,152) 7,125 (20,340) Other comprehensive income.................... - 1,253 - 3,243 --------- --------- --------- --------- Comprehensive net income (loss)..................... $ 20,724 $ (3,899) $ 7,125 $(17,097) --------- --------- --------- --------- --------- --------- --------- --------- Income (loss) per share - Basic...................... $ 1.06 $ (0.26) $ 0.37 $ (1.04)
'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
2. Oncothyreon to present at BIO CEO & Investor Conference 2009
3. Oncothyreon reports third quarter 2008 financial results
4. Oncothyreon to present at Rodman & Renshaw Annual Global Investment Conference
5. Oncothyreon announces November 6th webcast of third quarter 2008 financial results and corporate update conference call
6. Oncothyreon to present at BIO Investor Forum 2008
7. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
8. Oncothyreon announces prioritization plan for development programs
9. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
10. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
11. Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... June 17, 2013 zuChem Inc., ... health and nutrition, announced today that the United ... 2 patents - US 8,367,346 entitled “Methods for ... entitled "Process for producing D-Mannitol." These two patents ... of natural food sweetener products from abundant, renewable ...
(Date:6/17/2013)... Z Trim Holdings, Inc. (OTC Markets: ... ingredients to a variety of industries, today announced ... application at this year,s annual Institute of Food ... , July 13-16. The Company will demonstrate how ... in meat products thereby helping manufacturers lower costs ...
(Date:6/17/2013)... 17, 2013 Yongye International, Inc. (NASDAQ:   ... and distributor of crop nutrient products in ... today that its common stock will resume trading on ... at 7:15 a.m. Eastern Time. As previously ... Monday, March 18, 2013 following Yongye,s notification that the ...
(Date:6/16/2013)... CO (PRWEB) June 16, 2013 This training ... the Scrum team, people outside the software industry or those ... of what it is. , The topics that will ... scrum framework, scrum roles, scrum meetings, scrum artifacts, and scrum ... the following cities: , Denver, CO June 28, 2013 , ...
Breaking Biology Technology:zuChem Receives Two Polyol Patents 2Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 2Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 2Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 4Affordable Scrum Trainings in Denver, CO – 8 PDUs (June 28, 2013) by Conscires Agile Practices 2
... /Xinhua-PRNewswire/ -- Tiens Biotech Group (USA),Inc. (the "Company" or ... for the second quarter and six months ended,June 30, ... 2008, revenue was $19.7 million,an increase of 37.2% compared ... Net income for the second quarter of 2008 ...
... - Company to Host Conference Call at 4:30 p.m. ET ... PCYC ) today reported financial results for its fourth ... for the fourth quarter of,fiscal 2008 was $4.6 million, or ... or $0.27 per share, for the fourth quarter of fiscal ...
... improvements for converting plant biomass into biofuelas an alternative ... Eddy Rubin, Director of the U.S. Department of Energy ... edition of the journal Nature . In ... forward for how emerging genomic technologies will contribute to ...
Cached Biology Technology:Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 2Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 3Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 4Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 5Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 6Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 7Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 8Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 9Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 10Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 11Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 12Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 13Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 14Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 2Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 3Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 4Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 5Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 6DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature 2DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature 3DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature 4
(Date:6/17/2013)... 17, 2013How kids eat their food may turn out to ... a new study out of St. Michael,s Hospital. , ... found a significant association between poor eating habits in ... or "bad" cholesterol, putting them at risk for ... in the Canadian Medical Association Journal today. ...
(Date:6/17/2013)... In research published in Biochemical and Biophysical Research ... that can detect new, previously unknown viruses. The technique ... when doctors have not identified a particular virus as ... In the new approach, scientists use blood serum as ... Taking advantage of the complete deciphering of the human ...
(Date:6/17/2013)... , June 17, 2013 As mobile ... need to secure them grows exponentially, and biometric ... report from Heavy Reading Insider ( ... Heavy Reading ( www.heavyreading.com ). ... the market for biometric authentication on smartphones, analyzing ...
Breaking Biology News(10 mins):Poor eating behaviors may put preschoolers at risk for later health problems 2Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3
... found that some individuals in the vegetative and minimally ... themselves, can learn and thereby demonstrate at least a ... (20 September) online edition of Nature Neuroscience . ... tested whether patients in vegetative and minimally conscious states ...
... assistant researcher Durrell Kapan recently published a paper, Man ... Vector-Borne Disease Dynamics, in PLoS One . ... patterns in mega-cities may be a critically overlooked factor ... dengue fever, infecting 50-100 million people annually. "Even ...
... conditions, such as chronic pain, cancer and diabetes, require medications ... on an as-needed basis, over a long period of time. ... heat source, an implanted electronic chip or other stimuli as ... But thus far, none of these methods can reliably do ...
Cached Biology News:Scientists find that individuals in vegetative states can learn 2UH Manoa researcher examines possible implications of daily commute and mosquito-borne diseases 2Using magnetism to turn drugs on and off 2